Comparison of two immunomagnetic separation technologies to deplete T cells from human blood samples

Oscar Lara, Xiaodong Tong, Maciej Zborowski, Sherif Farag, Jeffrey J. Chalmers

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The objective of this study was to compare the performance of two immunomagnetic separation technologies to deplete T cells from buffy coats of human blood. Specifically, two versions of the commercial MACS® Technology: MiniMACS and SuperMACS, and a prototype, flow-through system, the QMS, were evaluated. Peripheral blood mononuclear leukocytes (PBL) were isolated from buffy coats and an immunomagnetic separation of CD3+ cells was conducted using company and optimized labeling protocols. To mimic peripheral blood containing bone marrow purged hematopoietic stem cells, HSC, CD34 expressing-cells (KG1a) were spiked into PBL prior to T-cell depletion once optimized depletion conditions were determined. Once the labeling protocol was optimized, the MiniMACS system performed well by producing a highly enriched CD3+ fraction, and a respectable level of depletion of T cells and recovery of KG1a cells in the depleted fraction; an average log10 depletion of T cells of 2.88 ± 0.17 and an average recovery of the KG1a cells of 60.8 ± 5.94% (n = 14). The performance of the SuperMACS system was very similar with an average log10 depletion of T cells of 2.89 ± 0.22 and an average recovery of KG1a of 63.1 ± 8.55% (n = 10). In contrast, the QMS system produced an average log10 depletion of T cells of 3.98 ± 0.33 (n = 16) with a corresponding average recovery of 57.9 ± 16.6% of the spiked CD34+ cells. The aforementioned QMS performance values were obtained using sorting speeds ranging from 2.5 × 104 to 1.7 × 105 cells per second. It is suggested that the lack of a 100% recovery of the unlabeled KG1a cells is the result of a previously reported "drafting" phenomena which pulls unlabeled cells in the direction of the magnetically labeled cells thereby resulting in loss of the unlabeled cells.

Original languageEnglish (US)
Pages (from-to)66-80
Number of pages15
JournalBiotechnology and Bioengineering
Volume94
Issue number1
DOIs
StatePublished - May 5 2006
Externally publishedYes

Fingerprint

Immunomagnetic Separation
T-cells
Blood
Technology
T-Lymphocytes
Recovery
Labeling
Mononuclear Leukocytes
Stem cells
Sorting
Glycocalyx
Bone
Hematopoietic Stem Cells
Bone Marrow

Keywords

  • Cell separation
  • HCS transplantation
  • Immunomagnetic
  • MACS
  • QMS
  • T cell depletion

ASJC Scopus subject areas

  • Biotechnology
  • Microbiology

Cite this

Comparison of two immunomagnetic separation technologies to deplete T cells from human blood samples. / Lara, Oscar; Tong, Xiaodong; Zborowski, Maciej; Farag, Sherif; Chalmers, Jeffrey J.

In: Biotechnology and Bioengineering, Vol. 94, No. 1, 05.05.2006, p. 66-80.

Research output: Contribution to journalArticle

Lara, Oscar ; Tong, Xiaodong ; Zborowski, Maciej ; Farag, Sherif ; Chalmers, Jeffrey J. / Comparison of two immunomagnetic separation technologies to deplete T cells from human blood samples. In: Biotechnology and Bioengineering. 2006 ; Vol. 94, No. 1. pp. 66-80.
@article{d5361079152344d8a6b3ad9e19ef1e0f,
title = "Comparison of two immunomagnetic separation technologies to deplete T cells from human blood samples",
abstract = "The objective of this study was to compare the performance of two immunomagnetic separation technologies to deplete T cells from buffy coats of human blood. Specifically, two versions of the commercial MACS{\circledR} Technology: MiniMACS and SuperMACS, and a prototype, flow-through system, the QMS, were evaluated. Peripheral blood mononuclear leukocytes (PBL) were isolated from buffy coats and an immunomagnetic separation of CD3+ cells was conducted using company and optimized labeling protocols. To mimic peripheral blood containing bone marrow purged hematopoietic stem cells, HSC, CD34 expressing-cells (KG1a) were spiked into PBL prior to T-cell depletion once optimized depletion conditions were determined. Once the labeling protocol was optimized, the MiniMACS system performed well by producing a highly enriched CD3+ fraction, and a respectable level of depletion of T cells and recovery of KG1a cells in the depleted fraction; an average log10 depletion of T cells of 2.88 ± 0.17 and an average recovery of the KG1a cells of 60.8 ± 5.94{\%} (n = 14). The performance of the SuperMACS system was very similar with an average log10 depletion of T cells of 2.89 ± 0.22 and an average recovery of KG1a of 63.1 ± 8.55{\%} (n = 10). In contrast, the QMS system produced an average log10 depletion of T cells of 3.98 ± 0.33 (n = 16) with a corresponding average recovery of 57.9 ± 16.6{\%} of the spiked CD34+ cells. The aforementioned QMS performance values were obtained using sorting speeds ranging from 2.5 × 104 to 1.7 × 105 cells per second. It is suggested that the lack of a 100{\%} recovery of the unlabeled KG1a cells is the result of a previously reported {"}drafting{"} phenomena which pulls unlabeled cells in the direction of the magnetically labeled cells thereby resulting in loss of the unlabeled cells.",
keywords = "Cell separation, HCS transplantation, Immunomagnetic, MACS, QMS, T cell depletion",
author = "Oscar Lara and Xiaodong Tong and Maciej Zborowski and Sherif Farag and Chalmers, {Jeffrey J.}",
year = "2006",
month = "5",
day = "5",
doi = "10.1002/bit.20807",
language = "English (US)",
volume = "94",
pages = "66--80",
journal = "Biotechnology and Bioengineering",
issn = "0006-3592",
publisher = "Wiley-VCH Verlag",
number = "1",

}

TY - JOUR

T1 - Comparison of two immunomagnetic separation technologies to deplete T cells from human blood samples

AU - Lara, Oscar

AU - Tong, Xiaodong

AU - Zborowski, Maciej

AU - Farag, Sherif

AU - Chalmers, Jeffrey J.

PY - 2006/5/5

Y1 - 2006/5/5

N2 - The objective of this study was to compare the performance of two immunomagnetic separation technologies to deplete T cells from buffy coats of human blood. Specifically, two versions of the commercial MACS® Technology: MiniMACS and SuperMACS, and a prototype, flow-through system, the QMS, were evaluated. Peripheral blood mononuclear leukocytes (PBL) were isolated from buffy coats and an immunomagnetic separation of CD3+ cells was conducted using company and optimized labeling protocols. To mimic peripheral blood containing bone marrow purged hematopoietic stem cells, HSC, CD34 expressing-cells (KG1a) were spiked into PBL prior to T-cell depletion once optimized depletion conditions were determined. Once the labeling protocol was optimized, the MiniMACS system performed well by producing a highly enriched CD3+ fraction, and a respectable level of depletion of T cells and recovery of KG1a cells in the depleted fraction; an average log10 depletion of T cells of 2.88 ± 0.17 and an average recovery of the KG1a cells of 60.8 ± 5.94% (n = 14). The performance of the SuperMACS system was very similar with an average log10 depletion of T cells of 2.89 ± 0.22 and an average recovery of KG1a of 63.1 ± 8.55% (n = 10). In contrast, the QMS system produced an average log10 depletion of T cells of 3.98 ± 0.33 (n = 16) with a corresponding average recovery of 57.9 ± 16.6% of the spiked CD34+ cells. The aforementioned QMS performance values were obtained using sorting speeds ranging from 2.5 × 104 to 1.7 × 105 cells per second. It is suggested that the lack of a 100% recovery of the unlabeled KG1a cells is the result of a previously reported "drafting" phenomena which pulls unlabeled cells in the direction of the magnetically labeled cells thereby resulting in loss of the unlabeled cells.

AB - The objective of this study was to compare the performance of two immunomagnetic separation technologies to deplete T cells from buffy coats of human blood. Specifically, two versions of the commercial MACS® Technology: MiniMACS and SuperMACS, and a prototype, flow-through system, the QMS, were evaluated. Peripheral blood mononuclear leukocytes (PBL) were isolated from buffy coats and an immunomagnetic separation of CD3+ cells was conducted using company and optimized labeling protocols. To mimic peripheral blood containing bone marrow purged hematopoietic stem cells, HSC, CD34 expressing-cells (KG1a) were spiked into PBL prior to T-cell depletion once optimized depletion conditions were determined. Once the labeling protocol was optimized, the MiniMACS system performed well by producing a highly enriched CD3+ fraction, and a respectable level of depletion of T cells and recovery of KG1a cells in the depleted fraction; an average log10 depletion of T cells of 2.88 ± 0.17 and an average recovery of the KG1a cells of 60.8 ± 5.94% (n = 14). The performance of the SuperMACS system was very similar with an average log10 depletion of T cells of 2.89 ± 0.22 and an average recovery of KG1a of 63.1 ± 8.55% (n = 10). In contrast, the QMS system produced an average log10 depletion of T cells of 3.98 ± 0.33 (n = 16) with a corresponding average recovery of 57.9 ± 16.6% of the spiked CD34+ cells. The aforementioned QMS performance values were obtained using sorting speeds ranging from 2.5 × 104 to 1.7 × 105 cells per second. It is suggested that the lack of a 100% recovery of the unlabeled KG1a cells is the result of a previously reported "drafting" phenomena which pulls unlabeled cells in the direction of the magnetically labeled cells thereby resulting in loss of the unlabeled cells.

KW - Cell separation

KW - HCS transplantation

KW - Immunomagnetic

KW - MACS

KW - QMS

KW - T cell depletion

UR - http://www.scopus.com/inward/record.url?scp=33646541423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646541423&partnerID=8YFLogxK

U2 - 10.1002/bit.20807

DO - 10.1002/bit.20807

M3 - Article

VL - 94

SP - 66

EP - 80

JO - Biotechnology and Bioengineering

JF - Biotechnology and Bioengineering

SN - 0006-3592

IS - 1

ER -